Urso 250 and Abdominal distension - a phase IV clinical study of FDA data

Summary:

Abdominal distension is reported as a side effect among people who take Urso 250 (ursodiol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aldactone, and have Hepatic neoplasm malignant.

The phase IV clinical study analyzes which people have Abdominal distension when taking Urso 250. It is created by eHealthMe based on reports of 5,057 people who have side effects when taking Urso 250 from the FDA, and is updated regularly.

What is Urso 250?

Urso 250 has active ingredients of ursodiol. eHealthMe is studying from 5,080 Urso 250 users. Check the latest studies of Urso 250.

What is Abdominal distension?

Abdominal distension is found to be associated with 2,572 drugs and 3,640 conditions by eHealthMe. Check the latest studies of Abdominal distension.

On Jul, 15, 2026

5,057 people reported to have side effects when taking Urso 250.
Among them, 51 people (1.01%) have Abdominal distension.

Could Urso 250 cause Abdominal distension?

Among these 51 people:

How long have people been on Urso 250 when they have Abdominal distension? *

What is the gender of people who have Abdominal distension when taking Urso 250? *

female: 46 %
male: 54 %

What is the age of people who have Abdominal distension when taking Urso 250? *

What are other drugs people take besides Urso 250? *

What are other side effects people have besides Abdominal distension? *

Ascites (accumulation of fluid in the abdominal cavity): 16 people, 31.37%
Fever: 15 people, 29.41%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 23.53%
Diarrhea: 11 people, 21.57%
Rashes (redness): 11 people, 21.57%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 10 people, 19.61%
Abdominal Pain: 10 people, 19.61%
Pleural Effusion (water on the lungs): 8 people, 15.69%
Headache (pain in head): 8 people, 15.69%
Hypotension (abnormally low blood pressure): 7 people, 13.73%

What are the existing conditions these people have? *

Hepatic Neoplasm Malignant (liver cancer): 11 people, 21.57%
Thrombocytopenia (decrease of platelets in blood): 6 people, 11.76%
Immunodeficiency Disorders: 6 people, 11.76%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 6 people, 11.76%
Hepatitis C: 6 people, 11.76%
High Blood Pressure: 6 people, 11.76%
Constipation: 5 people, 9.80%
Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem): 5 people, 9.80%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 4 people, 7.84%
Cough: 4 people, 7.84%

* Approximation only. Some reports may have incomplete information.

Do you take Urso 250 and have Abdominal distension?

- Check whether Abdominal distension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Urso 250:

Urso 250 (5,080 reports)

Browse all side effects of Urso 250:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal distension:

Abdominal distension (2,572 drugs)

Browse all the conditions that are associated with Abdominal distension:

Abdominal distension (3,640 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Urso 250) and Urso 250 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.